Relmada Therapeutics Inc (RLMD)
3.68
-0.04
(-1.08%)
USD |
NASDAQ |
May 03, 16:00
3.66
-0.02
(-0.54%)
After-Hours: 20:00
Relmada Therapeutics Total Liabilities (Quarterly): 12.19M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.19M |
| September 30, 2023 | 8.422M |
| June 30, 2023 | 10.70M |
| March 31, 2023 | 10.10M |
| December 31, 2022 | 12.47M |
| September 30, 2022 | 20.78M |
| June 30, 2022 | 18.92M |
| March 31, 2022 | 15.41M |
| December 31, 2021 | 15.06M |
| September 30, 2021 | 18.25M |
| June 30, 2021 | 13.92M |
| March 31, 2021 | 12.72M |
| December 31, 2020 | 12.60M |
| September 30, 2020 | 3.390M |
| June 30, 2020 | 2.326M |
| March 31, 2020 | 2.261M |
| September 30, 2019 | 2.537M |
| June 30, 2019 | 2.606M |
| March 31, 2019 | 2.130M |
| December 31, 2018 | 1.864M |
| September 30, 2018 | 10.30M |
| June 30, 2018 | 8.561M |
| Date | Value |
|---|---|
| March 31, 2018 | 7.112M |
| December 31, 2017 | 5.853M |
| September 30, 2017 | 4.149M |
| June 30, 2017 | 1.377M |
| March 31, 2017 | 1.368M |
| December 31, 2016 | 1.550M |
| September 30, 2016 | 2.348M |
| June 30, 2016 | 3.202M |
| March 31, 2016 | 2.513M |
| December 31, 2015 | 4.840M |
| September 30, 2015 | 6.649M |
| June 30, 2015 | 15.58M |
| March 31, 2015 | 25.36M |
| December 31, 2014 | 28.20M |
| September 30, 2014 | 48.57M |
| February 28, 2014 | 0.0412M |
| November 30, 2013 | 0.0403M |
| August 31, 2013 | 0.0337M |
| May 31, 2013 | 0.026M |
| February 28, 2013 | 0.012M |
| August 31, 2012 | 0.007M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.261M
Minimum
Mar 2020
20.78M
Maximum
Sep 2022
10.81M
Average
12.33M
Median
Total Liabilities (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | 8.198M |
| Lifecore Biomedical Inc | 256.99M |
| Harrow Inc | 241.75M |
| Corvus Pharmaceuticals Inc | 6.869M |
| Aquestive Therapeutics Inc | 163.90M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 97.55M |
| Shareholders Equity (Quarterly) | 85.36M |